Total Payments
$733.09
2024 Payments
$301.86
Companies
12
Transactions
38
Medicare Patients
1,304
Medicare Billing
$109,327
Payment Breakdown by Category
Food & Beverage$719.20 (98.1%)
Education$13.89 (1.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $719.20 | 37 | 98.1% |
| Education | $13.89 | 1 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $191.12 | 10 | $0 (2024) |
| Lilly USA, LLC | $146.54 | 7 | $0 (2024) |
| PFIZER INC. | $106.05 | 5 | $0 (2024) |
| Amgen Inc. | $62.03 | 3 | $0 (2024) |
| Astellas Pharma US Inc | $51.58 | 3 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $45.11 | 3 | $0 (2024) |
| ABBVIE INC. | $42.46 | 2 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $21.35 | 1 | $0 (2023) |
| IBSA Pharma Inc. | $17.99 | 1 | $0 (2023) |
| GlaxoSmithKline, LLC. | $17.79 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $301.86 | 14 | Lilly USA, LLC ($97.64) |
| 2023 | $200.93 | 11 | Novo Nordisk Inc ($66.43) |
| 2022 | $125.27 | 7 | ABBVIE INC. ($42.46) |
| 2021 | $105.03 | 6 | Novo Nordisk Inc ($73.12) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.92 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $31.74 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/15/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Biological | ||||||
| 09/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: PAIN | ||||||
| 06/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Respiratory | ||||||
| 05/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Diabetes | ||||||
| 05/02/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: Diabetes | ||||||
| 03/19/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: Bone Health | ||||||
| 03/19/2024 | Amgen Inc. | — | Education | In-kind items and services | $13.89 | General |
| 03/05/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Diabetes | ||||||
| 02/27/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.63 | General |
| 02/13/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 02/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Diabetes | ||||||
| 01/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: PAIN | ||||||
| 11/29/2023 | PFIZER INC. | TRUMENBA (Biological), PREVNAR 20, COMIRNATY | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: VACCINES | ||||||
| 11/08/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Diabetes | ||||||
| 10/17/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Diabetes | ||||||
| 08/29/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Diabetes | ||||||
| 07/12/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Biological | ||||||
| 06/28/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/07/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.17 | General |
| 05/31/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Urology | ||||||
| 05/17/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Diabetes | ||||||
| 02/07/2023 | IBSA Pharma Inc. | LICART (Drug), TIROSINT, TIROSINT | Food and Beverage | Cash or cash equivalent | $17.99 | General |
| Category: non-opioid analgesic | ||||||
| 01/23/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: INSOMNIA | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 524 | 690 | $148,720 | $46,629 |
| 2022 | 4 | 190 | 227 | $56,778 | $19,708 |
| 2021 | 3 | 68 | 68 | $12,020 | $4,020 |
| 2020 | 9 | 522 | 758 | $80,884 | $38,970 |
Total Patients
1,304
Total Services
1,743
Medicare Billing
$109,327
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 198 | 321 | $80,571 | $22,542 | 28.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 152 | 152 | $38,608 | $16,246 | 42.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 104 | 137 | $24,249 | $6,166 | 25.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 11 | $3,861 | $1,125 | 29.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 12 | 12 | $401.00 | $362.88 | 90.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 34 | 43 | $344.00 | $94.60 | 27.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 13 | 14 | $686.00 | $92.70 | 13.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 102 | 138 | $34,758 | $11,356 | 32.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 55 | 55 | $14,134 | $5,975 | 42.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $3,948 | $1,238 | 31.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 22 | $3,938 | $1,140 | 28.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 29 | 29 | $7,511 | $2,499 | 33.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 21 | 21 | $3,843 | $1,242 | 32.3% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 18 | 18 | $666.00 | $279.18 | 41.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 206 | 328 | $42,640 | $20,679 | 48.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 190 | 289 | $28,900 | $12,508 | 43.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 22 | 22 | $2,860 | $2,136 | 74.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 11 | 11 | $1,980 | $1,571 | 79.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 13 | 14 | $2,324 | $1,337 | 57.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 21 | 21 | $630.00 | $302.83 | 48.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 27 | 28 | $840.00 | $229.04 | 27.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 11 | 20 | $560.00 | $152.02 | 27.1% |
| 81003 | Automated urinalysis test | Office | 2020 | 21 | 25 | $150.00 | $55.35 | 36.9% |
About Kelly Bell, ARNP
Kelly Bell, ARNP is a Family healthcare provider based in Clermont, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1124162524.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kelly Bell, ARNP has received a total of $733.09 in payments from pharmaceutical and medical device companies, with $301.86 received in 2024. These payments were reported across 38 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($719.20).
As a Medicare-enrolled provider, Bell has provided services to 1,304 Medicare beneficiaries, totaling 1,743 services with total Medicare billing of $109,327. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Clermont, FL
- Active Since 02/18/2007
- Last Updated 06/27/2018
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1124162524
Products in Payments
- Ozempic (Drug) $112.70
- MOUNJARO (Drug) $77.67
- JARDIANCE (Drug) $68.87
- NURTEC ODT (Drug) $49.51
- Rybelsus (Drug) $41.62
- Veozah (Drug) $36.13
- TEPEZZA (Biological) $31.74
- FARXIGA (Drug) $29.13
- QULIPTA (Drug) $23.85
- XARELTO (Drug) $21.35
- PAXLOVID (Drug) $19.73
- TRUMENBA (Biological) $19.02
- UBRELVY (Drug) $18.61
- LICART (Drug) $17.99
- ELIQUIS (Drug) $17.79
- TRELEGY ELLIPTA (Drug) $17.79
- EVENITY (Biological) $16.40
- AIRSUPRA (Drug) $15.98
- GARDASIL 9 (Biological) $15.77
- Myrbetriq (Drug) $15.45
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Clermont
Mrs. Chantal Baptiste, Aprn, APRN
Family — Payments: $13,695
Family $13,695
Ashlee Koronka, Aprn, APRN
Family — Payments: $7,969
Family $7,969
Jessica Bean, Arnp, ARNP
Family — Payments: $5,976
Family $5,976
Mrs. Narissa Seelall, Aprn, APRN
Family — Payments: $5,676
Family $5,676
Tammy Covington, Np-C, NP-C
Family — Payments: $5,500
Family $5,500
Chelsea Merrow, Aprn, APRN
Family — Payments: $5,044
Family $5,044